Skip to main content
SpringerLink
Log in

Allopurinol/venetoclax

Tumour lysis syndrome and lack of efficacy: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Drozd-Sokolowska J, et al. The Clinical Tumor Lysis Syndrome in a Patient with Mixed Phenotype Acute Leukemia Undergoing Induction with Venetoclax and Azacitidine: A Case Report. Chemotherapy (Basel) 67: 173-177, No. 3, 2022. Available from: URL: http://doi.org/10.1159/000524182

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Allopurinol/venetoclax. Reactions Weekly 1924, 34 (2022). https://doi.org/10.1007/s40278-022-23387-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-23387-z

Search

Navigation